• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Interactions between a general practitioner and representatives of drug companies.

作者信息

O'Mahony B

出版信息

BMJ. 1993 Jun 19;306(6893):1649. doi: 10.1136/bmj.306.6893.1649.

DOI:10.1136/bmj.306.6893.1649
PMID:8324433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1678055/
Abstract
摘要

相似文献

1
Interactions between a general practitioner and representatives of drug companies.全科医生与制药公司代表之间的互动。
BMJ. 1993 Jun 19;306(6893):1649. doi: 10.1136/bmj.306.6893.1649.
2
Attitudes of general practitioners to their interactions with pharmaceutical companies: a qualitative study.
Ir Med J. 2002 Jul-Aug;95(7):199-202.
3
Reasons for not seeing drug representatives. Companies have to encourage doctors to prescribe their products.不见药品代表的原因。公司必须鼓励医生开他们的产品。
BMJ. 1999 Oct 9;319(7215):1002-3.
4
Dramaturgical study of meetings between general practitioners and representatives of pharmaceutical companies; Commentary: dramaturgical model gives valuable insight.全科医生与制药公司代表会面的戏剧学研究；评论：戏剧学模型提供了宝贵的见解。
BMJ. 2001;323(7327):1481-4. doi: 10.1136/bmj.323.7327.1481.
5
Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional study.经常会见制药行业代表的全科医生特征：全国性横断面研究。
BMJ. 2003 May 31;326(7400):1178-9. doi: 10.1136/bmj.326.7400.1178.
6
Reasons for not seeing drug representatives. Drug representatives have much to offer.不接待药品推销员的原因。药品推销员能提供很多东西。
BMJ. 1999 Oct 9;319(7215):1003.
7
MPs' report criticises influence of drugs industry on GP prescribing.议员报告批评制药行业对全科医生开药的影响。
BMJ. 2008 Jan 19;336(7636):111. doi: 10.1136/bmj.39462.487025.4E.
8
Pharmaceutical representatives. Guidelines exist on making effective use of time spent with representatives.医药代表。关于有效利用与医药代表相处时间已有相关指南。
BMJ. 1996 Oct 5;313(7061):881. doi: 10.1136/bmj.313.7061.881a.
9
Medicine and the pharmaceutical industry: a call to action.医学与制药行业：行动呼吁。
Am Fam Physician. 2007 May 15;75(10):1447, 1451; discussion 1451.
10
Residents and pharmaceutical representatives.住院医师和医药代表。
Can Fam Physician. 1998 Jul;44:1448.

引用本文的文献

1
Characteristics of materials distributed by drug companies. An evaluation of appropriateness.制药公司分发材料的特点。适宜性评估。
J Gen Intern Med. 1996 Oct;11(10):575-83. doi: 10.1007/BF02599024.

本文引用的文献

1
Scientific versus commercial sources of influence on the prescribing behavior of physicians.影响医生处方行为的科学因素与商业因素
Am J Med. 1982 Jul;73(1):4-8. doi: 10.1016/0002-9343(82)90911-1.
2
Doctors and the drug industry: too close for comfort.医生与制药行业：关系过近令人不安。
Br Med J (Clin Res Ed). 1986 Oct 11;293(6552):905-6. doi: 10.1136/bmj.293.6552.905.
3
Doctors, drug companies, and gifts.医生、制药公司与礼品。
JAMA. 1989;262(24):3448-51.
4
Doctors and detailers: therapeutic education or pharmaceutical promotion?医生与医药代表：是治疗学教育还是药品促销？
Int J Health Serv. 1989;19(4):663-79. doi: 10.2190/HUFK-5Y54-QX1E-AD62.